Page last updated: 2024-10-27

flumazenil and Amphetamine Abuse

flumazenil has been researched along with Amphetamine Abuse in 3 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research Excerpts

ExcerptRelevanceReference
"Patients seeking treatment for methylamphetamine dependence must cope with drug cravings as they engage in psychosocial treatments."2.76A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence. ( Baron, M; Hanselka, LL; Urschel, HC, 2011)
"12mg/kg/infusion) were tested, producing an inverted U-shaped dose-response curve."1.43The differential effects of alprazolam and oxazepam on methamphetamine self-administration in rats. ( Goeders, NE; Guerin, GF; Spence, AL, 2016)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spence, AL1
Guerin, GF1
Goeders, NE1
Urschel, HC1
Hanselka, LL1
Baron, M1
Ling, W1
Shoptaw, S1
Hillhouse, M1
Bholat, MA1
Charuvastra, C1
Heinzerling, K1
Chim, D1
Annon, J1
Dowling, PT1
Doraimani, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Double-Blind, Placebo Controlled Trial of Prometa Pharmacotherapy for the Treatment of Methamphetamine Abuse[NCT00260481]Phase 2/Phase 3120 participants (Actual)Interventional2006-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for flumazenil and Amphetamine Abuse

ArticleYear
A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:2

    Topics: Adolescent; Adult; Amines; Amphetamine-Related Disorders; Anticonvulsants; Behavior, Addictive; Cycl

2011
Double-blind placebo-controlled evaluation of the PROMETAâ„¢ protocol for methamphetamine dependence.
    Addiction (Abingdon, England), 2012, Volume: 107, Issue:2

    Topics: Adult; Amines; Amphetamine-Related Disorders; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug

2012

Other Studies

1 other study available for flumazenil and Amphetamine Abuse

ArticleYear
The differential effects of alprazolam and oxazepam on methamphetamine self-administration in rats.
    Drug and alcohol dependence, 2016, Sep-01, Volume: 166

    Topics: Alprazolam; Amphetamine-Related Disorders; Animals; Dose-Response Relationship, Drug; Flumazenil; Is

2016